Skip to main content
. 2020 May;20(2):254–261. doi: 10.17305/bjbms.2019.4392

FIGURE 1.

FIGURE 1

TaqMan relative expression level in serum for miR-23a and miR-181b, data normalized to U6 and expressed as fold change for controls, IBS and CRC. IBS: Irritable bowel syndrome; CRC: Colorectal cancer.